Home > Financial Ratios > PANACEA BIOTEC

PANACEA BIOTEC
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results

PANACEA BIOTEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 112.39-1,972.34-102.5855.10143.60

What is the latest Core EBITDA Growth ratio of PANACEA BIOTEC ?

The latest Core EBITDA Growth ratio of PANACEA BIOTEC is 112.39 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024112.39
Mar2023-1,972.34
Mar2022-102.58
Mar202155.10
Mar2020143.60

How is Core EBITDA Growth of PANACEA BIOTEC Trending?

Years Core EBITDA Growth % Change
Mar2024 112.39
Positive
Mar2023 -1972.34
Negative
Mar2022 -102.58
Negative
Mar2021 55.1
-61.63
Mar2020 143.6 -

Other Financial Ratios of PANACEA BIOTEC


Compare Core EBITDA Growth ratio of peers of PANACEA BIOTEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PANACEA BIOTEC ₹2,605.6 Cr -1.7% -0.3% 193.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,466.0 Cr 1.7% 2% -0.6% Stock Analytics
DIVIS LABORATORIES ₹177,298.0 Cr 0.4% -2% 37.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,538.0 Cr 6% 10.5% 13.6% Stock Analytics
CIPLA ₹127,140.0 Cr 6.8% 4.6% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,500.0 Cr 4.2% 1.3% -6.7% Stock Analytics


PANACEA BIOTEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PANACEA BIOTEC

-1.7%

-0.3%

193.2%

SENSEX

-1%

-3.2%

1.6%


You may also like the below Video Courses